The results showed that patients with a mean baseline body weight of 106.9 kg who were treated with CagriSema (2.4/2.4 mg) achieved 22.7% weight loss after 68 weeks, compared to 11.8% of those treated with cagrilintide 2.4 mg monotherapy and 16.1% of those treated with semaglutide 2.4 mg monotherapy, and to 2.3% of those receiving only the placebo [125]
Ross DS, Litofsky D, Ain KB, Bigos T, Brierley JD, Cooper DS, Haugen BR, Jonklaas J, Ladenson PW, Magner J, Robbins J, Skarulis MC, Steward DL, Maxon HR, Sherman SI
Lipohypertrophylumpy, thickened fat deposits from repeated traumaoccurs when patients inject the same spot repeatedly without rotation
Adv Sci 2023, 10, 2204794
A.Saeb-ParsyK.MurphyM
Patients who know their genetic profile can work with their PlexusDx provider to optimize dosing timing, meal composition, and supportive medicationsreducing unexpected surprises and improving treatment adherence